GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anixa Biosciences Inc (NAS:ANIX) » Definitions » E10

ANIX (Anixa Biosciences) E10 : $-0.61 (As of Jul. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Anixa Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Anixa Biosciences's adjusted earnings per share data for the three months ended in Jul. 2024 was $-0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.61 for the trailing ten years ended in Jul. 2024.

During the past 3 years, the average E10 Growth Rate was 2.30% per year. During the past 5 years, the average E10 Growth Rate was 6.30% per year. During the past 10 years, the average E10 Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Anixa Biosciences was 11.70% per year. The lowest was -10.70% per year. And the median was 2.80% per year.

As of today (2024-12-16), Anixa Biosciences's current stock price is $2.85. Anixa Biosciences's E10 for the quarter that ended in Jul. 2024 was $-0.61. Anixa Biosciences's Shiller PE Ratio of today is .


Anixa Biosciences E10 Historical Data

The historical data trend for Anixa Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anixa Biosciences E10 Chart

Anixa Biosciences Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.78 -0.73 -0.71 -0.74 -0.68

Anixa Biosciences Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -0.68 -0.63 -0.59 -0.61

Competitive Comparison of Anixa Biosciences's E10

For the Biotechnology subindustry, Anixa Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anixa Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's Shiller PE Ratio falls into.



Anixa Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Anixa Biosciences's adjusted earnings per share data for the three months ended in Jul. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=-0.1/132.7078*132.7078
=-0.100

Current CPI (Jul. 2024) = 132.7078.

Anixa Biosciences Quarterly Data

per share eps CPI Adj_EPS
201410 -0.319 100.176 -0.423
201501 0.373 98.604 0.502
201504 -0.237 99.824 -0.315
201507 -0.164 100.691 -0.216
201510 -0.137 100.346 -0.181
201601 -0.164 99.957 -0.218
201604 -0.150 100.947 -0.197
201607 -0.130 101.524 -0.170
201610 -0.120 101.988 -0.156
201701 -0.410 102.456 -0.531
201704 0.020 103.167 0.026
201707 -0.120 103.278 -0.154
201710 -0.110 104.070 -0.140
201801 -0.110 104.578 -0.140
201804 -0.080 105.708 -0.100
201807 -0.300 106.324 -0.374
201810 -0.290 106.695 -0.361
201901 -0.250 106.200 -0.312
201904 -0.130 107.818 -0.160
201907 -0.110 108.250 -0.135
201910 -0.100 108.577 -0.122
202001 -0.130 108.841 -0.159
202004 -0.120 108.173 -0.147
202007 -0.110 109.318 -0.134
202010 -0.090 109.861 -0.109
202101 -0.090 110.364 -0.108
202104 -0.080 112.673 -0.094
202107 -0.140 115.183 -0.161
202110 -0.130 116.696 -0.148
202201 -0.130 118.619 -0.145
202204 -0.120 121.978 -0.131
202207 -0.090 125.002 -0.096
202210 -0.120 125.734 -0.127
202301 -0.080 126.223 -0.084
202304 -0.070 127.992 -0.073
202307 -0.080 128.974 -0.082
202310 -0.090 129.810 -0.092
202401 -0.100 130.124 -0.102
202404 -0.100 132.289 -0.100
202407 -0.100 132.708 -0.100

Add all the adjusted EPS together and divide 10 will get our e10.


Anixa Biosciences  (NAS:ANIX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Anixa Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Anixa Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Anixa Biosciences Business Description

Traded in Other Exchanges
Address
3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Executives
Titterton Lewis H Jr director 6 AUTUMN LANE, SARATOGA SPRINGS NY 12866
Arnold M Baskies director 1235 SEQUOIA ROAD, CHERRY HILL NJ 08003
Amit Kumar director, officer: Chief Executive Officer C/O ACACIA RESEARCH CORPORATION, 500 NEWPORT CENTER DRIVE, 7TH FLOOR, NEWPORT BEACH CA 92660
Michael Catelani officer: COO & CFO 12100 WILSHIRE BOULEVARD, SUITE 1275, LOS ANGELES CA 90025
Emily Gottschalk director 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE CA 95118
John J Monahan director
David Cavalier director C/O AEOLUS PHARMACEUTICALS, INC., 23811 INVERNESS PLACE, LAGUNA NIGUEL CA 92677
Richard H Williams director C/O QUOKKA SPORTS INC, 525 BRANNAN ST GROUND FL, SAN FRANCISCO CA 94108
Dale Fox director 929 NOWITA PLACE, VENICE CA 90291
Andrea Belz director 1011 ALTA VISTA DRIVE, ALTADENA CA 91001
Tisha Stender officer: Chief Operating Officer 900 WALT WHITMAN ROAD, MELVILLE NY 11747
Robert Andrew Berman officer: President and CEO C/O ITUS CORPORATION, 12100 WILSHIRE BOULEVARD, SUITE 1275, LOS ANGELES CA 90025
John H. Roop officer: Sr. Vice President-Engineering C/O COPYTELE, INC., 900 WALT WHITMAN ROAD, MELVILLE NY 11747
Bruce F Johnson director 20 S. WACKER DR, CHICAGO IL 60606
Kent B. Williams director C/O COPYTELE INC., 900 WALT WHITMAN ROAD, MELVILLE NY 11747

Anixa Biosciences Headlines

From GuruFocus